Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7308 p79
17 July 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Patients prefer drug safety to effectiveness

Many patients with knee osteoarthritis are willing to forgo treatment effectiveness for a lower risk of side effects.

Liana Fraenkel, assistant professor of internal medicine and rheumatology at Yale school of medicine, New Haven, Connecticut, and colleagues interviewed 100 patients with symptomatic knee osteoarthritis about their treatment preferences. The researchers examined the relative importance of factors such as administration, risks, benefits and cost. Treatment options with these factors were described to patients who were then asked to rate each treatment for preference.

The researchers found that the risk for side effects had the greatest impact on patients’ choice, with non-selective non-steroidal anti-inflammatory drugs being among the least preferred options.

Despite being described as less effective than other drug treatments, topical capsaicin was the preferred treatment for 44 per cent of patients. The study is published in Archives of Internal Medicine (2004;164:1299).

Back to Top


©The Pharmaceutical Journal